Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 19301169)

Published in Cytotherapy on January 01, 2009

Authors

A Poloni1, G Maurizi, V Rosini, E Mondini, S Mancini, G Discepoli, S Biasio, G Battaglini, S Felicetti, E Berardinelli, F Serrani, P Leoni

Author Affiliations

1: Clinica di Ematologia, Dipartimento Scienze Mediche e Chirurgiche, Universita Politecnica delle Marche, Ancona, Italy. a.poloni@univpm.it

Articles citing this

CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood (2011) 2.16

Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int (2012) 1.20

Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression. Haematologica (2013) 0.92

Transcriptomic portrait of human Mesenchymal Stromal/Stem Cells isolated from bone marrow and placenta. BMC Genomics (2014) 0.90

Mesodermal progenitor cells (MPCs) differentiate into mesenchymal stromal cells (MSCs) by activation of Wnt5/calmodulin signalling pathway. PLoS One (2011) 0.89

CD271 as a marker to identify mesenchymal stem cells from diverse sources before culture. World J Stem Cells (2015) 0.87

Flow cytometric characterization of freshly isolated and culture expanded human synovial cell populations in patients with chronic arthritis. Arthritis Res Ther (2010) 0.85

Potential Effect of CD271 on Human Mesenchymal Stromal Cell Proliferation and Differentiation. Int J Mol Sci (2015) 0.85

Examining the feasibility of clinical grade CD271+ enrichment of mesenchymal stromal cells for bone regeneration. PLoS One (2015) 0.81

Optimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cells. Int J Biol Sci (2015) 0.81

Rapid clinical-scale propagation of mesenchymal stem cells using cultures initiated with immunoselected bone marrow CD105+ cells. J Cell Mol Med (2011) 0.79

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality? Int J Mol Sci (2016) 0.76

Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review. Stem Cell Res Ther (2015) 0.75

Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction. Stem Cell Res Ther (2017) 0.75

Articles by these authors

Multicentre observational study of the natural history of left-sided acute diverticulitis. Br J Surg (2011) 2.16

Prospective randomized multicentre study comparing stapler haemorrhoidopexy with Doppler-guided transanal haemorrhoid dearterialization for third-degree haemorrhoids. Colorectal Dis (2012) 2.12

Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant (2002) 2.09

Effects of cryopreservation on lymphocyte immunophenotype and function. J Immunol Methods (2003) 1.99

Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood (2000) 1.79

Adult colonic intussusception caused by malignant tumor of the transverse colon. Am Surg (1999) 1.68

0.75% and 0.5% ropivacaine for axillary brachial plexus block: a clinical comparison with 0.5% bupivacaine. Reg Anesth Pain Med (1999) 1.51

Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology (1994) 1.42

Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem (2000) 1.41

Value of antigen and antibody detection in the serological diagnosis of invasive aspergillosis in patients with hematological malignancies. Eur J Clin Microbiol Infect Dis (1994) 1.30

The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia. Br J Haematol (1999) 1.29

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood (2001) 1.27

Acute megakaryoblastic leukemia: experience of GIMEMA trials. Leukemia (2002) 1.22

Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci U S A (1994) 1.17

Differentiation of iron deficiency from thalassaemia trait: a new approach. Haematologica (1988) 1.14

Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clin Pharmacol Ther (2009) 1.09

Automated measurement of red blood cell microcytosis and hypochromia in iron deficiency and beta-thalassemia trait. Arch Pathol Lab Med (1992) 1.04

Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. Cytotherapy (2008) 1.01

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. Clin Infect Dis (1999) 1.01

Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib. Leukemia (2013) 1.01

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol (1998) 1.00

Regulation of procoagulant factors in mononuclear phagocytes. Haemostasis (1984) 0.99

Seton or glue for trans-sphincteric anal fistulae: a prospective randomized crossover clinical trial. Colorectal Dis (2011) 0.99

Antibiotic prophylaxis in elective laparoscopic cholecystectomy. Lack of need or lack of evidence? Surg Endosc (2004) 0.98

The first 1000 cases of Italian Endovenous-laser Working Group (IEWG). Rationale, and long-term outcomes for the 1999-2003 period. Int Angiol (2006) 0.98

Ovine Echinococcus granulosus transmission dynamics in the province of Rio Negro, Argentina, 1980-1999. Vet Parasitol (2001) 0.97

Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplant (1999) 0.96

A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts. Oncogene (2000) 0.94

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study. Blood Cancer J (2013) 0.93

Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol. Br J Haematol (1997) 0.92

Ultrasound-guided reduction of an incarcerated Spigelian hernia. Ultrasound Med Biol (2001) 0.91

Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. Am J Pathol (1995) 0.90

Bone marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: comparison with clinical response and patients outcome. Int J Immunopathol Pharmacol (2006) 0.89

Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J Cell Physiol (2001) 0.89

Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma. Br J Dermatol (2007) 0.88

Identification of blast cells in peripheral blood through automatic assessment of nuclear density: a new tool for monitoring patients with acute leukaemia. Br J Haematol (1987) 0.88

Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. Bone Marrow Transplant (1998) 0.88

Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides. J Clin Pathol (2003) 0.87

Antibodies against galactosyl (alpha 1----3) galactose in connective tissue diseases. Arthritis Rheum (1991) 0.86

Activation of neutrophil collagenase in periodontitis. Infect Immun (1999) 0.86

Control program of hydatid disease in the province of Río Negro Argentina. 1980-1997. Bol Chil Parasitol (2001) 0.86

The effect of weak bases on lysosomal enzyme secretion by mononuclear phagocytes. Biochem Pharmacol (1982) 0.85

Factor Xa is a fibroblast mitogen via binding to effector-cell protease receptor-1 and autocrine release of PDGF. Am J Physiol Cell Physiol (2001) 0.85

Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group. Haematologica (1999) 0.85

Humoral immune response against hepatitis C virus. J Biol Regul Homeost Agents (2003) 0.84

Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies. J Biol Regul Homeost Agents (2003) 0.84

Enzymatic synthesis of S-aminoethyl-L-cysteine from pantetheine. Biochim Biophys Acta (1992) 0.84

Anastomotic leaks after anterior resection for mid and low rectal cancer: survey of the Italian Society of Colorectal Surgery. Tech Coloproctol (2008) 0.83

Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine. Leuk Lymphoma (2006) 0.83

A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation. Clin Infect Dis (2001) 0.83

[Tubercular enteral fistulas]. Minerva Chir (1989) 0.83

Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. Haematologica (1998) 0.83

Management of gingival vitiligo with the use of a tattoo technique. J Periodontol (1998) 0.82

Postoperative analgesia by combined continuous infusion and patient-controlled epidural analgesia (PCEA) following hip replacement: ropivacaine versus bupivacaine. Acta Anaesthesiol Scand (2001) 0.82

Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia. Leukemia (2002) 0.82

Rate of infection and of reinfection by Echinococcus granulosus in rural dogs of the province of Rio Negro, Argentina. Vet Parasitol (2000) 0.82

A survey on canine leishmaniasis and phlebotomine sand flies in central Italy. Res Vet Sci (2009) 0.82

Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. Leukemia (2006) 0.81

Highly active antiretroviral therapy induces specific changes in effector and central memory T cell sub-populations. AIDS (2001) 0.81

Primary Hodgkin's lymphoma of the sigmoid colon. Haematologica (1986) 0.81

Guidelines for the diagnosis and therapy of the vein and lymphatic disorders. Int Angiol (2005) 0.81

Pneumonectomy: quality of life and long-term results. Minerva Chir (2012) 0.81

Molecular aspects of adipoepithelial transdifferentiation in mouse mammary gland. Stem Cells (2014) 0.80

Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate. Cell Prolif (2011) 0.80

Double-blind randomized phase I study on the clinical tolerance and biological effects of natural and recombinant interferon-beta. J Interferon Res (1992) 0.80

T-cell prolymphocytic leukaemia: does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literature. Ann Oncol (1999) 0.80

Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study. Br J Haematol (2000) 0.80

Differences in survivin location and Bcl-2 expression in CD30+ lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical study. Br J Dermatol (2007) 0.80

Treatment of relapsed adult acute lymphoblastic leukemia with fludarabine and cytosine arabinoside followed by granulocyte colony-stimulating factor (FLAG-GCSF). Leuk Lymphoma (1997) 0.80

Treatment of chronic myeloid leukemia in the blastic phase with fludarabine, cytosine arabinoside and G-CSF (FLAG). Eur J Haematol (2000) 0.80

Long term results of interferon treatment in hairy cell leukemia. Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL). Leuk Lymphoma (1994) 0.80

Giant neutrophils with increased peroxidase activity. Another evidence of dysgranulopoiesis in AIDS. Am J Clin Pathol (1987) 0.80

Clinical, functional and quality of life changes after balneokinesis with sulphurous water in patients with varicose veins. Vasa (2003) 0.79

[Surgical treatment of tumors of the ampulla of Vater by local resection]. G Chir (1999) 0.79

Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience. Bone Marrow Transplant (2001) 0.79

Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia. Leuk Lymphoma (1994) 0.79

Single lung transplantation for emphysema. Lessons learned on the field. The Lung Transplant Group of the Ospedale Maggiore of Milan. Int Surg (1992) 0.79

A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera. Ann Hematol (1994) 0.78

Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Leukemia (1996) 0.78

Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term alpha-IFN treatment. Ann Hematol (1993) 0.78

t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia. Br J Haematol (2000) 0.77